PeopleMichael Wyand
Michael Wyand
Michael Wyand, DVM, PhDCEO, Oxeia BiopharmaFrom building cGMP facilities to licensing immunotherapies to Big Pharma, Dr. Wyand’s technical and operational expertise is unmatched. His experience turning scientific ideas into market-ready therapies is a blueprint for CYT-108’s future.
active0
Roles
team_member
Timeline
Current Company
